新接受血液透析患者与腹膜透析患者生存率的比较:一项采用倾向评分匹配的5年前瞻性队列研究。
Comparison of survival rates between incident hemodialysis patients and peritoneal dialysis patients: a 5-year prospective cohort study with propensity score matching.
作者信息
Miyazaki Mami, Sasaki Kensuke, Nakashima Ayumu, Takahashi Akira, Ishiuchi Naoki, Tamura Ryo, Osaki Yosuke, Doi Shigehiro, Masaki Takao
机构信息
Department of Nephrology, Hiroshima University Hospital, 1-2-3 Kasumi, Minami-Ku, Hiroshima, 734-8551, Japan.
Department of Stem Cell Biology and Medicine, Graduate School of Biomedical & Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.
出版信息
Clin Exp Nephrol. 2023 May;27(5):419-426. doi: 10.1007/s10157-023-02315-3. Epub 2023 Jan 23.
BACKGROUND
The effect of dialytic modality at the start of renal replacement therapy on prognosis is controversial.
METHODS
This multicenter, prospective cohort study included patients undergoing incident hemodialysis (HD) (n = 646) and peritoneal dialysis (PD) (n = 72). We excluded patients who lacked complete data for 3 months. One-to-one propensity score (PS) matching was performed before between-group comparison of survival rates (Kaplan-Meier method and log-rank test) and identification of factors affecting prognosis (Cox proportional-hazards regression analysis).
RESULTS
We enrolled 621 and 71 patients undergoing HD and PD, respectively (overall mean ± standard deviation age: 74 ± 13 years); 20% had cardiovascular disease (CVD). The median follow-up period was 41 (interquartile range 24-66) months. Following PS matching, we analyzed 65 patients undergoing HD and PD each. The 5-year overall survival rates did not differ between the groups (P = 0.97). The PD group exhibited a better CVD-related survival rate (P = 0.03). PD yielded adjusted hazard ratios for all-cause and CVD-related mortality of 0.99 (95% confidence interval [CI] 0.49-1.99, P = 0.97) and 3.92 (95% CI 1.05-14.7, P = 0.04), respectively. Age (P < 0.001) and the use of a central venous catheter (CVC) at dialytic initiation (P = 0.02) were independent risks for all-cause mortality; whereas, only the use of a CVC (P = 0.01) was an independent risk for CVD-related mortality.
CONCLUSION
Although no differences were observed in overall survival, CVD-related survival may be better with dialytic initiation with PD than with HD.
背景
肾脏替代治疗开始时透析方式对预后的影响存在争议。
方法
这项多中心前瞻性队列研究纳入了接受首次血液透析(HD)(n = 646)和腹膜透析(PD)(n = 72)的患者。我们排除了缺乏3个月完整数据的患者。在进行生存率组间比较(Kaplan-Meier法和对数秩检验)以及确定影响预后的因素(Cox比例风险回归分析)之前,进行了一对一倾向评分(PS)匹配。
结果
我们分别纳入了621例接受HD和71例接受PD的患者(总体平均±标准差年龄:74±13岁);20%患有心血管疾病(CVD)。中位随访期为41(四分位间距24 - 66)个月。经过PS匹配后,我们对每组65例接受HD和PD的患者进行了分析。两组的5年总生存率无差异(P = 0.97)。PD组的CVD相关生存率更高(P = 0.03)。PD导致全因死亡率和CVD相关死亡率的调整后风险比分别为0.99(95%置信区间[CI] 0.49 - 1.99,P = 0.97)和3.92(95% CI 1.05 - 14.7,P = 0.04)。年龄(P < 0.001)和透析开始时使用中心静脉导管(CVC)(P = 0.02)是全因死亡率的独立危险因素;而只有使用CVC(P = 0.01)是CVD相关死亡率的独立危险因素。
结论
虽然在总生存率方面未观察到差异,但透析开始时采用PD的CVD相关生存率可能优于HD。